by National Research Council of Science & Technology Bang Eun-kyoung(left) from the KIST’s Center for Neuro-Medicine are discussing the efficacy of RNA stabilizer containing zinc complex. Credit: Korea Institute of Science and Technology (KIST) MERS, which struck South Korea in a 2015 outbreak, was caused by a coronavirus, the same family of viruses that is...
by University of St Andrews A new anti-viral drug developed by Pneumagen, a University of St Andrews spin out company, has had positive results in laboratory tests against COVID-19. Pneumagen Ltd, a company focused on treating infectious disease and developing oncology treatments by targeting the human glycome, today (28 April 2020) announced results from three...
A team led by scientists at the Broad Institute, MIT, and Massachusetts General Hospital has developed a prototype device that uses microfluidics to sort cell types extracted from clinical samples for RNA sequencing. Credit: Miguel Reyes “This platform allows us to isolate specific cell subsets in a sample, so we can perform RNA sequencing and...
